🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

London Stock Exchange Group

3 posts
Read More

LSEG’s $3.5bn Octus talks test whether private-credit data can justify a 9x sales valuation

London Stock Exchange Group is discussing a roughly $3.5 billion acquisition of Octus, adding proprietary private-credit intelligence to a data business already being rebuilt around artificial intelligence. The strategic fit is clear, but an implied valuation near nine times sales and a sharp negative share-price reaction show investors want evidence that scarce private-market data can generate returns matching the price.